drugset / Trial / NCT07345715

Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy

NCT07345715

Recruiting 96 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to compare the efficacy of using oral Melatonin versus nebulized Dexmedetomidine in limitation of emergence agitation in children undergoing adenotonsillectomy.

Timeline

Start
2025-07-01
Primary completion
2027-07-01
Completion
2027-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 2 ug/kg Inhaled
Subject Melatonin Small molecule 0.2 mg/kg Oral
Comparator Midazolam Small molecule 0.5 mg/kg Oral

Indications